Seegene launched a dedicated diagnostic system for diagnosing COVID-19 variants on ECCMID

Seoul, Korea, May 23, 2021 /PRNewswire/-Seegene Inc. (KQ 096530) is a biotechnology company specializing in molecular diagnostics. Its unique system for diagnosing COVID-19 variants was again recognized at this year’s European Clinical Microbiology Conference ECCMID.

Dr. Seegene Guy William Lee, The director of marketing strategy used his latest COVID-19 variant diagnostic test to introduce the diagnostic system with the theme “SARS-CoV-2 and variants “full screening” solution”. Lee said: “South Korea has taken excellent control measures at the beginning of the pandemic because of the one-stop diagnostic system that can perform large-scale testing.” He added: “The system enables the diagnostic process from sample collection to PCR testing. Complete it all at once, helping local authorities quickly control the pandemic.”

However, due to the rapid spread of more and more COVID-19 variants, the effectiveness of the current diagnostic system has been questioned, and there have been reports that vaccines may not provide adequate protection. The Centers for Disease Control and Prevention has previously stated that after predicting that global COVID-19 cases will increase sharply with the continued surge of variants, variants are expected to promote the increase of new cases in the United States in May.

When talking about Seegene’s “Comprehensive Screening Solution”, Director Lee suggested that the system will effectively respond to the prolonged COVID-19 pandemic. The “Full Screening Solution” is a one-step system that can verify whether an individual is infected with a wild-type coronavirus or a virus variant through a single real-time PCR test. Currently, after the standard PCR test, the health department is forced to perform another round of genome sequencing to distinguish the presence of COVID-19 variants, which automatically leads to a longer test time.

In the context of Seegene’s “Comprehensive Screening Solution”, the company’s latest variant diagnostic test, Allplex^{TM value} SARS-CoV-2 main detection methods and Allplex^{TM value} I tested the SARS-CoV-2 variant.Almighty^{TM value} SARS-CoV-2 Master is an ideal method to screen for COVID-19 because it can provide a result of whether a person is COVID-19 positive or variant positive. After a round of testing, Seegene’s Allplex^{TM value} SARS-CoV-2 variant I analysis helps to identify multiple mutant variants in a single reaction.

Almighty^{TM value} SARS-CoV-2 Master Assay can detect a total of 10 targets, including 4 coronavirus genes (E gene, RdRP gene, N gene and S gene) and 5 most clearly defined virus variants, especially in B1. 1.7, B.1.351, P.1 and B.1.1.207. Seegene’s variant diagnostic test is the first such test that can simultaneously detect multiple coronavirus genes and distinguish virus variants, including finding variants that are more contagious and lethal. As the pandemic and wild type and its virus variants continue to prevail, this is an ideal and economical way to screen coronavirus genes. Director Lee added: “Among the rapidly spreading virus variants, Seegene’s “Comprehensive Screening Solution” will play a key role in controlling the spread of the COVID-19 pandemic.”

Also at this year’s World Science Symposium, Dr. Nakmoon Sung of Seegene Medical Foundation announced the results of clinical research on the detection of SARS-CoV-2 mutations (related to variants) and the detection of co-infection with respiratory pathogens. Among COVID-19 patients. Among the positive cases of COVID-19, the proportion of SARS-CoV-2 with mutations related to COVID-19 has increased from 1.2% a month ago to 3.5% in late February. Such clinical studies have shown that Seegene’s diagnostic test can screen for COVID-19 and can screen variants through a single PCR test. In terms of co-infection cases, 8.8% of COVID-19 positive cases were also co-infected with respiratory diseases, including influenza A, RSV, rhinovirus, metapneumovirus and Mycoplasma pneumoniae.

Regarding clinical data, Dr. Sung said: “Rapid diagnosis system is essential to control the recurrence of the COVID-19 pandemic,” he added, “One-step accurate diagnosis will become the global standard for detecting coronavirus. And other respiratory diseases, For the purpose of precise treatment“.

View original content to download multimedia:http://www.prnewswire.com/news-releases/seegene-introduces-an-exclusive-diagnostic-system-for-diagnosing-covid-19-variants-at-eccmid-301297361.html

Source Seegene